BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 32211315)

  • 1. Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma.
    Du J; Hou K; Mi S; Ji H; Ma S; Ba Y; Hu S; Xie R; Chen L
    Front Oncol; 2020; 10():208. PubMed ID: 32211315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A RNA methylation regulators contribute to malignant development and have a clinical prognostic effect on cervical cancer.
    Ma X; Li Y; Wen J; Zhao Y
    Am J Transl Res; 2020; 12(12):8137-8146. PubMed ID: 33437387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme.
    Wang LC; Chen SH; Shen XL; Li DC; Liu HY; Ji YL; Li M; Yu K; Yang H; Chen JJ; Qin CZ; Luo MM; Lin QX; Lv QL
    Front Oncol; 2020; 10():536875. PubMed ID: 33134160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic values of m6A RNA methylation regulators in differentiated Thyroid Carcinoma.
    Xu N; Chen J; He G; Gao L; Zhang D
    J Cancer; 2020; 11(17):5187-5197. PubMed ID: 32742465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
    Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
    FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
    Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
    Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
    Chang X; Lv YF; He J; Cao Y; Li CQ; Guo QN
    J Hepatocell Carcinoma; 2021; 8():85-101. PubMed ID: 33738268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
    Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y
    Front Genet; 2020; 11():994. PubMed ID: 33193582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.
    Zhang L; Qiao Y; Huang J; Wan D; Zhou L; Lin S; Zheng S
    Front Med (Lausanne); 2020; 7():556. PubMed ID: 33072775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Profile Analysis of m6A RNA Methylation Regulators Indicates They Are Immune Signature Associated and Can Predict Survival in Kidney Renal Cell Carcinoma.
    Fang J; Hu M; Sun Y; Zhou S; Li H
    DNA Cell Biol; 2020 Oct; ():. PubMed ID: 33085515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
    Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
    Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
    Pan J; Xu L; Pan H
    Front Oncol; 2020; 10():1444. PubMed ID: 32974164
    [No Abstract]   [Full Text] [Related]  

  • 17. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
    Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
    Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma.
    Cong P; Wu T; Huang X; Liang H; Gao X; Tian L; Li W; Chen A; Wan H; He M; Dai D; Li Z; Xiong L
    Front Cell Dev Biol; 2021; 9():709022. PubMed ID: 34589481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
    Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
    Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Expression Regulation for RNA m6A Regulators With Clinical Significance in Human Cancers.
    Liu X; Wang P; Teng X; Zhang Z; Song S
    Front Oncol; 2021; 11():624395. PubMed ID: 33718187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.